Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.22 (
cdc2
)
8,319
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cyclin
-dependent, proline-directed protein kinases normally function to execute critical cell cycle transitions; abnormal expression and/or viral subversion of the positive (cyclins) and negative (Pic1) regulatory subunits may contribute to neoplastic transformation and tumorigenesis. In addition to the binding of regulatory subunits, the enzymatic activities of the cyclin-dependent kinases, Cdc2 and
Cdk2
, are tightly regulated by site-specific protein phosphorylation events. Recent studies have identified a critical phosphorylation site (Thr-161) located within kinase Subdomain VIII that is necessary for Cdc2 activation, and enzymatic activities capable of carrying out this heterologous phosphorylation event have been detected in both Xenopus oocytes and human somatic cells. In this report, we characterize by molecular cloning a human homologue of the Xenopus Cdk-activating kinase (Cak, encoded by MO15); the novel human gene is designated (HS)CAK1. While only 75% identity is observed at the nucleotide level, the deduced amino acid sequence encoded by (HS)CAK1 is approximately 87% identical to that of the Xenopus MO15 gene in corresponding regions. The catalytic domain of (HS)
Cak1
, defined by conserved kinase Subdomains I through XI, exhibits considerable homology with (HS)Cdc2, suggesting that this kinase cascade involves closely related enzymes. Immunological studies with anti-Cak antibodies confirm the presence of specific immunoreactivity in highly purified preparations of the human Cdc2-activating kinase. The molecular characterization of (HS)CAK1 should facilitate studies of its physiological regulation, as well as its potential utility as a target for therapeutic intervention in the treatment of proliferative disorders.
...
PMID:Molecular cloning of the human CAK1 gene encoding a cyclin-dependent kinase-activating kinase. 820 56
We examined the changes that occurred in the two components of maturation-promoting factor (MPF),
cdc2 kinase
and cyclin B, during oocyte maturation in goldfish, using monoclonal antibodies against the C-terminal sequence of goldfish
cdc2 kinase
and Escherichia coli-produced full-length goldfish cyclin B. Immature oocytes contained a 35-kDa inactive
cdc2 kinase
. In addition to the 35-kDa form, a 34-kDa active
cdc2 kinase
was detected in oocytes undergoing germinal vesicle breakdown (GVBD).
Cyclin
B was absent in immature oocytes and appeared just before GVBD, coinciding exactly with the appearance of the 34-kDa active
cdc2 kinase
. Precipitation with p13suc1 beads and anticyclin B antibody revealed that cyclin B formed a complex with
cdc2 kinase
as soon as it appeared. MPF activation was induced by 1 ng cyclin B after introduction into immature oocytes or oocyte extracts. This corresponds to the amount of cyclin B found in mature oocytes (the concentration in the oocyte is 2 micrograms/ml). These results suggest that MPF activation in fish oocytes is induced by complex formation with preexisting
cdc2 kinase
and newly synthesized cyclin B during oocyte maturation, a situation differing from that in Xenopus and starfish, in which the
cdc2 kinase
-cyclin B complex is already present in immature oocytes. Unlike that in Xenopus, an inhibition of protein synthesis in unfertilized mature goldfish oocytes caused a decrease in the
cdc2 kinase
activity/cyclin B protein level and led to a progression from meiotic metaphase to meiotic anaphase. This result indicates that the mechanisms of maintaining MPF activity in mature goldfish oocytes differ from those in Xenopus.
...
PMID:Behavior of the components of maturation-promoting factor, cdc2 kinase and cyclin B, during oocyte maturation of goldfish. 822 52
Cyclin
dependent kinases (
CDK
's) are kinases that interact with cyclins and regulate cell division. Genomic clones encoding human CDK2, CDK4, and CDK5 were obtained and mapped to their respective chromosomal loci using fluorescence in situ hybridization on human lymphocyte metaphase spreads. Interestingly, CDK2 and CDK4 were located at the same position, 12q13, and CDK5 was mapped to 7q36. 12q13 has been shown to be associated with chromosome alterations such as amplifications and translocations in solid tumors. 7q36 does not appear to be a major site of chromosome alterations in tumors. As CDK2 and CDK4 appear to be important in regulating the human cell cycle, it is possible that the alterations of the 12q13 locus in tumors may involve changes in the regulation of CDK2 and CDK4 genes.
...
PMID:Chromosomal mapping of human CDK2, CDK4, and CDK5 cell cycle kinase genes. 827 15
p34cdc2 kinase plays a key role in the initiation of mitosis. The activity of this kinase requires the binding of a protein, named cyclin, to it. The kinase forms a heterodimer with cyclin.
Cyclin
A or B is the counterpart of this complex. The differences in the activity between cyclin A/
cdc2 kinase
and cyclin B/
cdc2 kinase
have not been cleared. In recent years, the other
cdc2
-like kinases were identified. One of them was CDK2 (cyclin dependent kinase 2). CDK2 could rescue the defect of the budding yeast CDC28 mutation, which arrested the cells at a point named START, in G1 phase. Then, CDK2 was thought to be worked at G1 through S phase in a cell cycle, but the details on the role of this kinase has not been cleared so far. In this study, we separated the human cyclin A/
cdc2 kinase
, cyclin B/
cdc2 kinase
and CDK2, each other by use of column chromatography, and characterized the each kinase. These kinases had the same substrate specificities when the synthesized peptides were tested. They phosphorylated the threonine residue in the sequence -Thr-Pro-Lys-Lys-Ala- but hardly phosphorylated threonine residue the sequence -Thr-Pro-Lys-Ala-Lys-. They had some differences in the substrate-preference when the native proteins were tested. In a cell cycle of human cells, the activity of
cdc2 kinase
increased at G2/M phase and the activity of CDK2 was high from S through M phase. These data suggested that
cdc2 kinase
works at the transition from G2 to M phase and that CDK2 works from G1 through G2/M phase. They could phosphorylate different protein-substrates having the common phosphorylated sequence -Thr-Pro-X-Lys-.
...
PMID:[The characterization of human cdc2 kinase and CDK2]. 830 38
Inactivation of the cyclin-p34cdc2 protein kinase complex is a major requirement for anaphase onset and exit from mitosis. To facilitate identification of specific molecules that regulate this event in mammalian cells, I have developed a cell-free assay in which
cdc2 kinase
associated with a chromosomal fraction from metaphase tissue culture cells is inactivated by a cell-cycle-regulated cytosolic system. In vitro kinase inactivation requires ATP, Mg2+ and the dephosphorylation of one or more sites in the chromosomal fraction by protein phosphatase 1 and/or 2A.
Cyclin
B is destroyed during inactivation, while the level of p34cdc2 remains constant. Ammonium sulfate fractionation resolves the cytosolic inactivating system into at least two distinct protein components that are both required for inactivation and are differentially regulated during mitosis.
...
PMID:Inactivation of cdc2 kinase during mitosis requires regulated and constitutive proteins in a cell-free system. 831 79
Cyclin
A associates with both the p34
cdc2
and p33
cdk2
kinases and is involved at two major check-points (G1-S and G2-M) of the cell cycle. The cyclin has been identified in multimeric protein complexes that incorporate the E2F transcription factor, the p33
cdk2
kinase, and p107, which is related to the retinoblastoma protein. Therefore, cyclin A provides a link between studies on the cell-cycle machinery and those aiming to elucidate the modulation of cell proliferation and regulation of gene expression by oncogenes and growth-suppressor proteins. The modification of cyclin A expression in a human liver cancer by the insertion of hepatitis B viral DNA into the cyclin A gene, and binding of cyclin A to the oncogenic E1A viral protein in adenovirus-infected cells suggest that the cyclin is implicated in human carcinogenesis. In addition, cyclin A might also be considered as a marker for tumor-cell proliferation in oncology. With these views in mind, it is now important to extend these observations to other types of cancer.
...
PMID:Oncogenic activation of cyclin A. 838 33
In eucaryotes, M-phase promoting factor (MPF) triggers meiosis in germ cells and mitosis in somatic cells. MPF is composed of two proteins of which one is homologous with the protein kinase encoded by gene
cdc2
of Schizosaccharomyces pombe (p34cdc2) and the other is a cyclin whose concentration oscillates during the cell cycle. Inactivation of p34cdc2 (MPF) requires cyclin degradation, which occurs during the metaphase-anaphase transition of the M-phase.
Cyclin
degradation is not only associated with cell cycle progression, but is also required for this event. At the G2/M transition, p34cdc2 protein kinase is activated and catalyzes phosphorylation of numerous key proteins, thus enabling cell changes to occur. p34cdc2 undergoes multiple-site phosphorylation in a cell cycle-dependent manner. At onset of mitosis, the protein phosphatase cdc25 catalyzes dephosphorylation of the p34cdc2 kinase at the threonine 14 and tyrosine 15 sites. This event may be the rate-limiting step controlling onset of mitosis in cells of vertebrates. A second protein kinase, encoded by the proto-oncogene c-mos, acts as a cytostatic factor preventing cyclin degradation and keeping unfertilized eggs from progressing beyond the second meiotic metaphase.
...
PMID:[Control of cell division in eucaryotes]. 839 83
Human cyclins A and B1 were assembled with the
cdk2
or
cdc2
protein to reconstitute their respective kinase activities in vitro. Both cyclins complemented either
cdk2
or
cdc2
, yielding kinase activities that supported the phosphorylation of histone H1. Activation of
cdk2
-catalyzed H1 kinase activity by cyclin A required a 10-min preincubation of the two components, whereas
cdc2 kinase
supported phosphate incorporation without a detectable time lag upon the addition of cyclin B1, suggesting a slower association rate of
cdk2
with cyclin A compared with
cdc2
and cyclin B1. Both
cdk2
and cyclin A, as well as
cdc2
and cyclin B1, formed stable complexes in the absence of ATP and substrate that could be isolated after glycerol gradient centrifugation. Incubation of the isolated complexes with ATP and histone H1 supported the phosphorylation of the substrate.
Cyclin
A-activated
cdk2
or
cdc2
phosphorylated p107, a pRB-related cellular protein, 10 times more effectively than the cyclin B1-complexed kinases. This was most likely due to a direct association of cyclin A with p107 (Ewen, M. E., Faha, B., Harlow, E., and Livingston, D. (1992) Science 255, 85-87; Faha, B., Ewen, M. E., Tsai, L.-H., Livingston, D., and Harlow, E. (1992) Science 255, 87-90). The reconstituted
cdc2
-cyclin B1 complex incorporated 4-5-fold more phosphate into the p34 subunit of the three-subunit (p70, p34, and p14) human single-stranded DNA-binding protein (also called RP-A), a DNA replication and DNA repair factor, than
cdc2
-cyclin A. No detectable phosphorylation of the p34 protein was observed with
cdk2
complexed with either cyclin B1 or A. These data indicate that both cyclins as well as the catalytic subunits are important factors in controlling the rate of phosphorylation of a given substrate. The cyclin-activated
cdc2
family kinases may target their cellular substrates through cyclin-mediated protein-protein interactions.
...
PMID:Characterization of the in vitro reconstituted cyclin A or B1-dependent cdk2 and cdc2 kinase activities. 839 7
DNA replication in mammalian cells occurs in discrete nuclear foci. Here we show that terminally differentiated myotubes can be induced to reenter S phase and show the same pattern of replication foci as cycling cells. We used this cellular system to analyze the interaction of cell cycle proteins with these foci in vivo.
Cyclin
A and
cdk2
, but not cyclin B1 and
cdc2
, were specifically localized at nuclear replication foci, just like the replication protein proliferating cell nuclear antigen. A potential target of cyclin A and
cdk2
is the 34 kd subunit of replication protein A (RPA34). In contrast with the 70 kd subunit, which localizes to the foci, RPA34 was not detected at these replication sites, which may reflect a transient interaction. The specific localization of cyclin A and
cdk2
at nuclear replication foci provides a direct link between cell cycle regulation and DNA replication.
...
PMID:Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication. 840 87
Cyclin
B-
cdc2
complexes are kept inactive by inhibitory phosphorylations on Thr-14 and Tyr-15 of
cdc2
until they are dephosphorylated at the end of G2 by the phosphatase cdc25. Recent work has suggested that a small region of cyclin B, which we call the P box, may contribute part of a phosphatase-activating domain to cdc25. Individual conservative substitutions at three invariant residues within the P box yield mutant cyclin B proteins that bind
cdc2
in vitro and then show the predicted cell cycle arrest, with cdc25 remaining in the low activity interphase form and cyclin B-
cdc2
complexes remaining phosphorylated and inactive. While the low activity interphase form of cdc25 cannot act on
cdc2
complexed with a mutant P box cyclin, the high activity M phase form of cdc25 can. These results demonstrate that the P box domain of cyclin B is required for cdc25 activation and support a two-step mechanism for the cdc25-dependent activation of cyclin B-
cdc2
.
...
PMID:Functional analysis of the P box, a domain in cyclin B required for the activation of Cdc25. 840 95
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>